• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

莫能菌素和氯喹对嵌合毒素的内吞作用及毒性的影响

The effect of monensin and chloroquine on the endocytosis and toxicity of chimeric toxins.

作者信息

Ippoliti R, Ginobbi P, Lendaro E, D'Agostino I, Ombres D, Benedetti P A, Brunori M, Citro G

机构信息

Istituto Pasteur-Fondazione Cenci Bolognetti, Department of Biochemical Sciences A. Rossi-Fanelli, University of Rome La Sapienza, Italy.

出版信息

Cell Mol Life Sci. 1998 Aug;54(8):866-75. doi: 10.1007/s000180050214.

DOI:10.1007/s000180050214
PMID:9760993
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11147355/
Abstract

The toxicity of two conjugates containing ribosome-inactivating proteins (RIPs, i.e. saporin and ricin-A chain x-linked to transferrin) has been measured on a prostatic cancer line (PC3) naturally overexpressing the transferrin receptor, in the presence of monensin and chloroquine. This paper investigates whether the increased toxicity of Tf-RIPs induced by monensin and chloroquine may be due to alterations of the normal endocytotic pathway of the complexes mediated by the transferrin receptor. Monensin, besides inducing alkalinization of normally acid intracellular compartments, causes an accumulation of the receptor-bound Tf-RIP in a perinuclear region contiguous to the cisternae of the trans-Golgi network. Chloroquine, though increasing the intracellular pH, seems not to modify the endocytotic pathway of these chimeric molecules. We believe that the enhanced toxicity of the Tf-RIPs may be related to intracellular alkalinization (i.e., endosomal or lysosomal pH) rather than to the effects on the recycling of transferrin receptor-bound toxins. We conclude that the efficacy of chimeric toxins may be modulated not only by the carrier used for their engineering but also by addition of drugs able to influence the stability and activation of the toxins inside the cell.

摘要

在莫能菌素和氯喹存在的情况下,已在天然过表达转铁蛋白受体的前列腺癌细胞系(PC3)上测定了两种含有核糖体失活蛋白(RIPs,即与转铁蛋白x连锁的皂草素和蓖麻毒素A链)的缀合物的毒性。本文研究了莫能菌素和氯喹诱导的Tf-RIPs毒性增加是否可能归因于转铁蛋白受体介导的复合物正常内吞途径的改变。莫能菌素除了诱导正常酸性细胞内区室的碱化外,还会使受体结合的Tf-RIP在与反式高尔基体网络池相邻的核周区域积累。氯喹虽然会提高细胞内pH值,但似乎不会改变这些嵌合分子的内吞途径。我们认为Tf-RIPs毒性增强可能与细胞内碱化(即内体或溶酶体pH值)有关,而不是与对转铁蛋白受体结合毒素再循环的影响有关。我们得出结论,嵌合毒素的疗效不仅可以通过用于其工程改造的载体来调节,还可以通过添加能够影响毒素在细胞内稳定性和激活的药物来调节。

相似文献

1
The effect of monensin and chloroquine on the endocytosis and toxicity of chimeric toxins.莫能菌素和氯喹对嵌合毒素的内吞作用及毒性的影响
Cell Mol Life Sci. 1998 Aug;54(8):866-75. doi: 10.1007/s000180050214.
2
Assessment of ligand effects in intracellular trafficking of ricin A chain using anti-ricin hybridomas.利用抗蓖麻毒素杂交瘤评估蓖麻毒素A链细胞内运输中的配体效应。
Cancer Res. 1991 Mar 15;51(6):1689-93.
3
A chimeric saporin-transferrin conjugate compared to ricin toxin: role of the carrier in intracellular transport and toxicity.与蓖麻毒素相比,一种嵌合型皂草毒素-转铁蛋白偶联物:载体在细胞内运输和毒性中的作用。
FASEB J. 1995 Sep;9(12):1220-5. doi: 10.1096/fasebj.9.12.7672515.
4
Retinoic acid disrupts the Golgi apparatus and increases the cytosolic routing of specific protein toxins.视黄酸会破坏高尔基体,并增加特定蛋白质毒素的胞质转运。
J Cell Biol. 1994 May;125(4):743-53. doi: 10.1083/jcb.125.4.743.
5
Complete inhibition of transferrin recycling by monensin in K562 cells.莫能菌素对K562细胞中转铁蛋白循环的完全抑制作用。
J Biol Chem. 1984 Dec 10;259(23):14762-72.
6
Saporin and ricin A chain follow different intracellular routes to enter the cytosol of intoxicated cells.皂草素和蓖麻毒素A链通过不同的细胞内途径进入中毒细胞的胞质溶胶。
FEBS J. 2005 Oct;272(19):4983-95. doi: 10.1111/j.1742-4658.2005.04908.x.
7
Blocking effect of human serum but not of cerebrospinal fluid on ricin A chain immunotoxin potentiation by monensin or carrier protein-monensin conjugates.
Cancer Res. 1992 Feb 1;52(3):623-30.
8
The effect of AZT and chloroquine on the activities of ricin and a saporin-transferrin chimeric toxin.
Biochem Pharmacol. 2005 Aug 15;70(4):560-9. doi: 10.1016/j.bcp.2005.04.048.
9
In vitro fusion of endocytic vesicles: effects of reagents that alter endosomal pH.内吞小泡的体外融合:改变内体pH值的试剂的作用
J Cell Biochem. 1996 Jul;62(1):27-39. doi: 10.1002/(sici)1097-4644(199607)62:1<27::aid-jcb4>3.0.co;2-3.
10
Influence of cytotoxicity enhancers in combination with human serum on the activity of CD22-recombinant ricin A against B cell lines, chronic and acute lymphocytic leukemia cells.细胞毒性增强剂与人血清联合使用对CD22重组蓖麻毒素A针对B细胞系、慢性和急性淋巴细胞白血病细胞活性的影响。
Leukemia. 1999 Feb;13(2):241-9. doi: 10.1038/sj.leu.2401262.

引用本文的文献

1
Targeted Toxins for the Treatment of Prostate Cancer.用于治疗前列腺癌的靶向毒素
Biomedicines. 2021 Aug 9;9(8):986. doi: 10.3390/biomedicines9080986.
2
Bifunctional small molecules that mediate the degradation of extracellular proteins.介导细胞外蛋白质降解的双功能小分子。
Nat Chem Biol. 2021 Sep;17(9):947-953. doi: 10.1038/s41589-021-00851-1. Epub 2021 Aug 19.
3
Antibiotic monensin synergizes with EGFR inhibitors and oxaliplatin to suppress the proliferation of human ovarian cancer cells.抗生素莫能菌素与表皮生长因子受体(EGFR)抑制剂及奥沙利铂协同作用,以抑制人卵巢癌细胞的增殖。
Sci Rep. 2015 Dec 7;5:17523. doi: 10.1038/srep17523.
4
Immunotoxins constructed with ribosome-inactivating proteins and their enhancers: a lethal cocktail with tumor specific efficacy.免疫毒素由核糖体失活蛋白及其增强子构建:具有肿瘤特异性疗效的致命鸡尾酒。
Curr Pharm Des. 2014;20(42):6584-643. doi: 10.2174/1381612820666140826153913.
5
Endothelin-converting enzyme 2 differentially regulates opioid receptor activity.内皮素转化酶2差异性调节阿片受体活性。
Br J Pharmacol. 2015 Jan;172(2):704-19. doi: 10.1111/bph.12833. Epub 2014 Sep 5.
6
Opioid receptor function is regulated by post-endocytic peptide processing.阿片受体功能受内吞后肽加工过程的调控。
J Biol Chem. 2014 Jul 11;289(28):19613-26. doi: 10.1074/jbc.M113.537704. Epub 2014 May 20.
7
Saporin-S6: a useful tool in cancer therapy.蓖麻毒素 S6:癌症治疗的有用工具。
Toxins (Basel). 2013 Oct 7;5(10):1698-722. doi: 10.3390/toxins5101698.
8
Transferrin-oligomers as potential carriers in anticancer drug delivery.转铁蛋白寡聚体作为抗癌药物递送中的潜在载体。
Pharm Res. 2004 Nov;21(11):1985-92. doi: 10.1023/b:pham.0000048188.69785.94.